FindTrial
Sign In

Neuroprotective effects of erythropoietin in patients with carbon monoxide poisoning

A comparison study of erythropoietin in patients with carbon monoxide poisoning: a double blind randomized control study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12002576
Enrollment
Unknown
Registered
2012-10-14
Start date
2008-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

carbon monoxide poisoning

Interventions

EPO:patients received EPO, 10,000 IU, daily for 1 week
Placebo:patients received normal saline

Sponsors

The first Affiliated Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 73 Years

Inclusion criteria

Inclusion criteria: We included patients aged 16 years or greater who were admitted for CO poisoning within 12 h after the end of CO exposure.

Exclusion criteria

Exclusion criteria: Exclusion criteria included (1) mixed poisoning; (2) pregnancy; (3) previous diagnosed neuropsychiatrical disease; (4) burn or any kind of trauma; and (5) hematological disease or cancer.

Design outcomes

Primary

MeasureTime frame
Barthel index;neurologic sequelae;NIHSS score;—

Countries

China

Contacts

Public ContactYang Wu
ccwuyang@163.com+86 13009001369

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026